omatic patients treated with CAS
compared with CEA (5.1% CAS vs 1.6% CEA; P ¼ .001).
Last, in a study by Hicks et al200 looking at almost
52,000 carotid procedures in the VQI, symptomatic
high risk patients deﬁned using Medicare criteria) had a
2.3% risk of stroke and death following CEA vs 3.6%